GHIT Fund Announces New Investments: A Total of Approximately 260 Million Yen in Shionogi, Takeda Pharmaceutical for New Malaria Drug Development

TOKYO, March 13, 2023 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 260 million yen (US$1.9 million1) for the research and development of a new malaria drug. This investment will help identify multiple promising…

Leave a Reply

Your email address will not be published. Required fields are marked *